Hamps Bio Limited
Fixed Price IPO · BSE
- Price band
- ₹51 - ₹51
- Lot size
- 2,000 shares
- Issue amount
- ₹6.22 cr
- Total subscription
- 1,050.21×
- Opens
- 13 Dec 2024
- Closes
- 17 Dec 2024
- Allotment
- 18 Dec 2024
- Listing
- 20 Dec 2024
Offer at a glance
Issue overview
- Issue size
- 12,20,000 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,02,000
- Fresh issue
- ₹6.22 cr
- Offer for sale
- ₹0 cr
- Registrar
- Bigshare Services Private Limited
- Listing exchange
- BSE
- Maximum investment
- ₹1,02,000
- Issue type
- Fixed Price IPO
- Shares before issue
- 31,36,000
- Shares after issue
- 43,56,000
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail | 2 | 4,000 | ₹2,04,000 |
| HNI | 3 | 6,000 | ₹3,06,000 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| RETAIL | 2.96 | 35.92 |
| NIB | 2.95 | 3.73 |
Financial performance
Company financials
In Lakhs. · Reported periods may include interim results.
Key performance indicators
| Metric | Oct-24 | Mar-24 | Mar-23 |
|---|---|---|---|
| EPS | 1.09 | 1.76 | 1.5 |
| ROE | 16.65 | 21.14 | 30.31 |
| ROCE | 18.53 | 18.31 | 17.43 |
| RONW | 9.19 | 14.84 | 26.34 |
| Pre IPO | 0 | 31.94 | 0 |
| Post IPO | 0 | 38.03 | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Hamps Bio Limited, incorporated in 2007, is engaged in marketing and distributing pharmaceutical products under the “Hamps” brand and freeze-dried and frozen FMCG items under the “FzyEzy” brand. Its pharmaceutical portfolio includes tablets, syrups, capsules, injectables, and powders, distributed across eight Indian states and union territories through 50+ distributors and online platforms such as Amazon, Flipkart, and Jio Mart. The company’s FMCG division offers freeze-dried and frozen products like strawberry, mango, and beet powders for both B2B and B2C markets, including contract manufacturing. With a portfolio of 180+ products across both verticals, Hamps Bio serves domestic and international markets and employed 78 people as of October 31, 2024.
Strengths
- Expert Leadership and Industry Experience: A seasoned and knowledgeable management team drives strategic growth, operational efficiency, and long-term business vision.
- Expansive Distribution Network with E-Retailing: Strong presence across 50+ distributors combined with availability on major e-commerce platforms such as Amazon and Flipkart ensures wide market reach and accessibility.
- Diverse Product Portfolio: With over 180 products spanning pharmaceuticals and FMCG categories, the company caters to a broad customer base across both domestic and international markets.
Risk factors
- Outstanding Litigation: Pending legal disputes may pose financial liabilities and harm the company’s reputation and business operations if outcomes are not favorable.
- Dependence on Third-Party Manufacturing: Heavy reliance on external manufacturers for pharmaceutical products exposes the company to potential supply chain disruptions, quality issues, and compliance risks.
- Single-Region Manufacturing Facility: Concentrating freeze-dried and frozen product manufacturing in Ankleshwar, Gujarat increases vulnerability to regional disruptions, which could adversely impact production and overall business continuity.
Promoters
Herrik Shah
Shrenik Shah
Pallavi Shah
Mitali Shah
Herrik Shah HUF
Shrenik Shah HUF
Registrar & documents
Lead manager
Marwadi Chandarana Intermediaries Brokers Private Limited
Registrar & contacts
Bigshare Services Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
2900/112, GIDC, Near Atul Limited, Ankleshwar, Bharuch 393 002
+91 8000006663
[email protected]Company website ↗Understanding HAMPS IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.